Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT01186068
Eligibility Criteria:
Inclusion Criteria:
* male or females at least 18 years of age
* diagnosis of stable erythematous rosacea
* \< 3 inflammatory lesions
* in good general health
* females must be non-pregnant and non-lactating
* must be willing to sign a consent form
Exclusion Criteria:
* have ocular, phymatous or other types of rosacea
* allergy to any ingredient in study drug
* participation in other investigational studies within 30 days of enrollment
* use of systemic steroids within 28 days of Baseline
* use of tetracycline antibiotics within 28 days of baseline
* use of products containing oxymetazoline within 14 days of baseline
* use of topical steroids witin treatment area 14 days prior to baseline
* use of Rx or OTC products for treatment of acne or rosacea within 14 days of baseline
* use of any product for reducing redness within the treatment area witin 14 days prior to baseline
* use of monoamine oxidase (MAO) inhibitors
* use of niacin \>/= 500mg/day
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01186068
Study Brief:
Protocol Section:
NCT01186068